771 related articles for article (PubMed ID: 30343637)
61. Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma.
Chen ATC; Serante AR; Ayres AS; Tonaki JO; Moreno RA; Shih H; Gattás GS; Lopez RVM; Dos Santos de Jesus GR; de Carvalho IT; Marotta RC; Marta GN; Feher O; Neto HS; Ribeiro ISN; Vasconcelos KGMDC; Figueiredo EG; Weltman E
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1122-1132. PubMed ID: 38232937
[TBL] [Abstract][Full Text] [Related]
62. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
[TBL] [Abstract][Full Text] [Related]
63. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
[TBL] [Abstract][Full Text] [Related]
64. Hypofractionated stereotactic photon radiotherapy of posteriorly located choroidal melanoma with five fractions at ten Gy--clinical results after six years of experience.
Dunavoelgyi R; Zehetmayer M; Gleiss A; Geitzenauer W; Kircher K; Georg D; Schmidt-Erfurth U; Poetter R; Dieckmann K
Radiother Oncol; 2013 Aug; 108(2):342-7. PubMed ID: 24044800
[TBL] [Abstract][Full Text] [Related]
65. Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma.
Morimoto M; Yoshioka Y; Kotsuma T; Adachi K; Shiomi H; Suzuki O; Seo Y; Koizumi M; Kagawa N; Kinoshita M; Hashimoto N; Ogawa K
Jpn J Clin Oncol; 2013 Aug; 43(8):805-12. PubMed ID: 23780990
[TBL] [Abstract][Full Text] [Related]
66. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
67. Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas.
Minniti G; Agolli L; Falco T; Scaringi C; Lanzetta G; Caporello P; Osti MF; Esposito V; Enrici RM
J Neurooncol; 2015 May; 122(3):559-66. PubMed ID: 25702193
[TBL] [Abstract][Full Text] [Related]
68. The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Ryken TC; Parney I; Buatti J; Kalkanis SN; Olson JJ
J Neurooncol; 2015 Dec; 125(3):551-83. PubMed ID: 26530266
[TBL] [Abstract][Full Text] [Related]
69. Hypofractionated stereotactic radiotherapy for low grade glioma at McGill University: long-term follow-up.
Roberge D; Souhami L; Olivier A; Leblanc R; Podgorsak E
Technol Cancer Res Treat; 2006 Feb; 5(1):1-8. PubMed ID: 16417396
[TBL] [Abstract][Full Text] [Related]
70. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.
Shi W; Palmer JD; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Bar-Ad V; Judy K; Farrell C; Simone N; Liu H; Dicker AP; Lawrence YR
J Neurooncol; 2016 May; 127(3):535-9. PubMed ID: 26821711
[TBL] [Abstract][Full Text] [Related]
71. Preliminary report of a phase I study of combined fractionated stereotactic radiosurgery and conventional external beam radiation therapy for unfavorable gliomas.
Regine WF; Patchell RA; Strottmann JM; Meigooni A; Sanders M; Young AB
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):421-6. PubMed ID: 10974456
[TBL] [Abstract][Full Text] [Related]
72. Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study.
Siker ML; Firat SY; Mueller W; Krouwer H; Schultz CJ
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):765-72. PubMed ID: 21236600
[TBL] [Abstract][Full Text] [Related]
73. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
VanderSpek L; Fisher B; Bauman G; Macdonald D
Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
[TBL] [Abstract][Full Text] [Related]
74. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
75. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
76. Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma.
Biau J; Chautard E; De Koning L; Court F; Pereira B; Verrelle P; Dutreix M
Radiat Oncol; 2017 Jul; 12(1):123. PubMed ID: 28754127
[TBL] [Abstract][Full Text] [Related]
77. Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas.
Wang B; Zhao P; Zhang Y; Ge M; Lan C; Li C; Pang Q; Xu S; Liu Y
J Neurooncol; 2018 Aug; 139(1):185-193. PubMed ID: 29696532
[TBL] [Abstract][Full Text] [Related]
78. Hypofractionated stereotactic reirradiation for recurrent glioblastoma.
Yazici G; Cengiz M; Ozyigit G; Eren G; Yildiz F; Akyol F; Gurkaynak M; Zorlu F
J Neurooncol; 2014 Oct; 120(1):117-23. PubMed ID: 25012955
[TBL] [Abstract][Full Text] [Related]
79. Hypofractionated radiotherapy boost for dose escalation as a treatment option for high-grade spinal cord astrocytic tumor.
Katoh N; Shirato H; Aoyama H; Onimaru R; Suzuki K; Hida K; Miyasaka K; Iwasaki Y
J Neurooncol; 2006 May; 78(1):63-9. PubMed ID: 16314938
[TBL] [Abstract][Full Text] [Related]
80. Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma.
Chua DT; Sham JS; Hung KN; Kwong DL; Kwong PW; Leung LH
Head Neck; 1999 Oct; 21(7):620-6. PubMed ID: 10487949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
